319 related articles for article (PubMed ID: 15818528)
1. [Measuring preferences for depressive health states].
König HH; Bernert S; Angermeyer MC
Psychiatr Prax; 2005 Apr; 32(3):122-31. PubMed ID: 15818528
[TBL] [Abstract][Full Text] [Related]
2. [The burden of depressive disorders in Germany - results from the European Study of the Epidemiology of Mental Disorders (ESEMeD)].
Günther OH; Friemel S; Bernert S; Matschinger H; Angermeyer MC; König HH
Psychiatr Prax; 2007 Sep; 34(6):292-301. PubMed ID: 17806016
[TBL] [Abstract][Full Text] [Related]
3. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders.
König HH; Roick C; Angermeyer MC
Eur Psychiatry; 2007 Apr; 22(3):177-87. PubMed ID: 17142014
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
[TBL] [Abstract][Full Text] [Related]
6. [Health Status of the German population: results of a representative survey using the EuroQol questionnaire].
König HH; Bernert S; Angermeyer MC
Gesundheitswesen; 2005 Mar; 67(3):173-82. PubMed ID: 15789280
[TBL] [Abstract][Full Text] [Related]
7. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
[TBL] [Abstract][Full Text] [Related]
8. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire.
König HH; Bernert S; Angermeyer MC; Matschinger H; Martinez M; Vilagut G; Haro JM; de Girolamo G; de Graaf R; Kovess V; Alonso J;
Med Care; 2009 Feb; 47(2):255-61. PubMed ID: 19169128
[TBL] [Abstract][Full Text] [Related]
9. The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning.
Günther O; Roick C; Angermeyer MC; König HH
Drug Alcohol Depend; 2007 Jan; 86(2-3):253-64. PubMed ID: 16930855
[TBL] [Abstract][Full Text] [Related]
10. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
[TBL] [Abstract][Full Text] [Related]
11. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
[TBL] [Abstract][Full Text] [Related]
12. [Discriminative ability, construct validity and sensitivity to change of the EQ-5D quality of life questionnaire in paranoid schizophrenia].
Konnopka A; Günther OH; Angermeyer MC; König HH
Psychiatr Prax; 2006 Oct; 33(7):330-6. PubMed ID: 17024582
[TBL] [Abstract][Full Text] [Related]
13. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments.
Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV
Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626
[TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
Khanna R; Jariwala K; Bentley JP
Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
[TBL] [Abstract][Full Text] [Related]
15. Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population.
Chang TJ; Tarn YH; Hsieh CL; Liou WS; Shaw JW; Chiou XG
J Formos Med Assoc; 2007 Dec; 106(12):1023-31. PubMed ID: 18194908
[TBL] [Abstract][Full Text] [Related]
16. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
[TBL] [Abstract][Full Text] [Related]
17. Validity of EQ-5D in general population of Taiwan: results of the 2009 National Health Interview and Drug Abuse Survey of Taiwan.
Yu ST; Chang HY; Yao KP; Lin YH; Hurng BS
Qual Life Res; 2015 Oct; 24(10):2541-8. PubMed ID: 25833013
[TBL] [Abstract][Full Text] [Related]
18. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
Yusof FA; Goh A; Azmi S
Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073
[TBL] [Abstract][Full Text] [Related]
19. Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.
Rand-Hendriksen K; Augestad LA
Value Health; 2012; 15(5):777-82. PubMed ID: 22867789
[TBL] [Abstract][Full Text] [Related]
20. Toward a Smaller Design for EQ-5D-5L Valuation Studies.
Yang Z; Luo N; Oppe M; Bonsel G; Busschbach J; Stolk E
Value Health; 2019 Nov; 22(11):1295-1302. PubMed ID: 31708067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
